- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 5.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 4.28M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 4.09M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.25M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.19M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $1.59M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $2.98M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $777.16K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $749.03K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.87M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.1M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $925.18K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $924.79K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.08M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.09M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.86M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.97M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.95M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.2M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.67 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.36 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.67 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.36 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $140.08K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $153.45K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.86M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.47M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.69M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.43M |
| Revenue | Q1 2026 · Mar 31, 2026 | $73 |
| Revenue | Q1 2026 · Mar 31, 2025 | $83 |